• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Acceptance and Commitment Therapy (ACT) vs Erenumab for High Frequency Episodic Migraine Without Aura: Time to Take the Gloves Off!

作者信息

Grazzi Licia, Rizzoli Paul

机构信息

Headache and Neuroalgology Unit, Neurological Institute "C. Besta" IRCCS Foundation, Milan, Italy.

John Graham Headache Center, Brigham & Women Faulkner Hospital, Boston, MA, USA.

出版信息

Headache. 2020 Apr;60(4):804-806. doi: 10.1111/head.13776. Epub 2020 Feb 25.

DOI:10.1111/head.13776
PMID:32096558
Abstract
摘要

相似文献

1
Acceptance and Commitment Therapy (ACT) vs Erenumab for High Frequency Episodic Migraine Without Aura: Time to Take the Gloves Off!接受与承诺疗法（ACT）与erenumab治疗无先兆高频发作性偏头痛：是时候放手一搏了！
Headache. 2020 Apr;60(4):804-806. doi: 10.1111/head.13776. Epub 2020 Feb 25.
2
Erenumab Plus Subcutaneous Immunoglobulin in a Patient With Comorbid Chronic Migraine and Myasthenia Gravis.依瑞奈单抗联合皮下注射免疫球蛋白治疗合并慢性偏头痛和重症肌无力的患者
Headache. 2020 Apr;60(4):787-788. doi: 10.1111/head.13779. Epub 2020 Feb 25.
3
Erenumab Efficacy on Comorbid Cluster Headache in Patients With Migraine: A Real-World Case Series.erenumab对偏头痛合并丛集性头痛患者的疗效：一项真实世界病例系列研究
Headache. 2020 Jun;60(6):1187-1195. doi: 10.1111/head.13832. Epub 2020 May 2.
4
Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study.erenumab预防高频发作性和慢性偏头痛：意大利erenumab真实生活研究（EARLY），意大利首个多中心、前瞻性真实生活研究。
Headache. 2021 Feb;61(2):363-372. doi: 10.1111/head.14032. Epub 2020 Dec 18.
5
Central effects of erenumab in migraine patients: An event-related functional imaging study.依那西普治疗偏头痛患者的中枢作用：一项事件相关功能成像研究。
Neurology. 2020 Nov 17;95(20):e2794-e2802. doi: 10.1212/WNL.0000000000010740. Epub 2020 Sep 11.
6
Timing and durability of response to erenumab in patients with chronic migraine.依那西普单抗治疗慢性偏头痛患者的应答时间和持久性。
Headache. 2021 Sep;61(8):1255-1263. doi: 10.1111/head.14193. Epub 2021 Aug 7.
7
Eptinezumab (Vyepti) for migraine prevention.依普他命单抗（Vyepti）用于预防偏头痛。
Med Lett Drugs Ther. 2020 Jun 1;62(1599):85-87.
8
Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries.依瑞奈umab（AMG 334），一种针对经典 CGRP 受体的单克隆拮抗剂抗体，不会损害人类孤立颅动脉对其他血管活性物质的舒张或收缩反应。
Cephalalgia. 2019 Dec;39(14):1745-1752. doi: 10.1177/0333102419867282. Epub 2019 Jul 31.
9
Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study.依瑞奈尤单抗用于慢性和阵发性偏头痛预防性治疗的真实世界持久性：回顾性真实世界研究。
Headache. 2022 Jan;62(1):78-88. doi: 10.1111/head.14218. Epub 2021 Nov 22.
10
Non-Responders to Treatment With Antibodies to the CGRP-Receptor May Profit From a Switch of Antibody Class.对降钙素基因相关肽受体抗体治疗无反应者可能会从抗体类型的转换中获益。
Headache. 2020 Feb;60(2):469-470. doi: 10.1111/head.13729. Epub 2019 Dec 24.

引用本文的文献

1
Forecasting migraine attacks by managing daily lifestyle: a systematic review as a basis to develop predictive algorithms.通过管理日常生活方式预测偏头痛发作：一项作为开发预测算法基础的系统评价
Pain Rep. 2025 Feb 5;10(2):e1247. doi: 10.1097/PR9.0000000000001247. eCollection 2025 Apr.
2
Alternative Treatments for Emotional Experiencing and Processing in People with Migraine or Tension-Type Headache: A Scoping Review.偏头痛或紧张型头痛患者情绪体验与处理的替代疗法：一项范围综述
Healthcare (Basel). 2024 Jun 29;12(13):1302. doi: 10.3390/healthcare12131302.
3
Ten open questions in migraine prophylaxis with monoclonal antibodies blocking the calcitonin-gene related peptide pathway: a narrative review.
阻断降钙素基因相关肽通路的单克隆抗体治疗偏头痛预防的 10 个开放性问题：叙述性综述。
J Headache Pain. 2023 Aug 1;24(1):99. doi: 10.1186/s10194-023-01637-7.
4
Evidence Mapping Based on Systematic Reviews of Cognitive Behavioral Therapy for Neuropathic Pain.基于系统评价的认知行为疗法治疗神经性疼痛的证据图谱。
Neural Plast. 2023 Mar 18;2023:2680620. doi: 10.1155/2023/2680620. eCollection 2023.
5
Effectiveness of Acceptance and Commitment Therapy in Central Pain Sensitization Syndromes: A Systematic Review.接纳与承诺疗法在中枢性疼痛敏化综合征中的有效性：一项系统评价
J Clin Med. 2021 Jun 19;10(12):2706. doi: 10.3390/jcm10122706.